Princeton Global Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Princeton Global Asset Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-20	Closed	-$1K	–	539
2022 Q2	$1K	Hold	20	–	–	﹤0.01%	524
2022 Q1	$1K	Hold	20	–	–	﹤0.01%	550
2021 Q4	$1K	Hold	20	–	–	﹤0.01%	497
2021 Q3	$1K	Hold	20	–	–	﹤0.01%	488
2021 Q2	$2K	Sell	20 -200	-91%	-$17K	﹤0.01%	500
2021 Q1	$20K	Sell	220 -911	-81%	-$90.4K	0.01%	325
2020 Q4	$106K	Buy	+1,131	New	+$90.1K	0.04%	192

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Princeton Global Asset Management's ARKG Position: Q3 2022 in Review

Princeton Global Asset Management sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2022, closing a stake of 20 shares — an estimated $1K sold.

Princeton Global Asset Management first reported a position in ARKG in Q4 2020 and held it in 7 quarters. The position peaked at $106K in Q4 2020. 311 funds tracked by Wall St. Rank hold ARKG as of Q3 2022.

Princeton Global Asset Management reported no remaining ARK Genomic Revolution ETF position as of Q3 2022 after selling out during the quarter.
Princeton Global Asset Management sold 20 ARK Genomic Revolution ETF shares in Q3 2022, an estimated $1K.
Princeton Global Asset Management first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 7 quarters.
Princeton Global Asset Management's ARK Genomic Revolution ETF position peaked at $106K in Q4 2020.
311 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2022.

Based on Princeton Global Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.